Axonics Operating Margin from 2010 to 2024
| AXNX Stock | USD 70.28 0.01 0.01% |
Check Axonics Modulation financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axonics Modulation's main balance sheet or income statement drivers, such as Net Interest Income of 17.6 M, Interest Income of 17 M or Depreciation And Amortization of 14.1 M, as well as many indicators such as Price To Sales Ratio of 7.92, Dividend Yield of 0.0 or PTB Ratio of 5.03. Axonics financial statements analysis is a perfect complement when working with Axonics Modulation Valuation or Volatility modules.
Axonics | Operating Margin |
Latest Axonics Modulation's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Axonics Modulation Technologies over the last few years. It is Axonics Modulation's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axonics Modulation's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.06 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Axonics Operating Margin Regression Statistics
| Arithmetic Mean | (79.14) | |
| Coefficient Of Variation | (88.78) | |
| Mean Deviation | 66.89 | |
| Median | (141.86) | |
| Standard Deviation | 70.27 | |
| Sample Variance | 4,938 | |
| Range | 142 | |
| R-Value | 0.89 | |
| Mean Square Error | 1,115 | |
| R-Squared | 0.79 | |
| Slope | 13.97 | |
| Total Sum of Squares | 69,127 |
Axonics Operating Margin History
About Axonics Modulation Financial Statements
Axonics Modulation investors use historical fundamental indicators, such as Axonics Modulation's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Axonics Modulation. Please read more on our technical analysis and fundamental analysis pages.
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation systems. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. Axonics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 517 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| V | Visa Class A | |
| MSFT | Microsoft |
Additional Tools for Axonics Stock Analysis
When running Axonics Modulation's price analysis, check to measure Axonics Modulation's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axonics Modulation is operating at the current time. Most of Axonics Modulation's value examination focuses on studying past and present price action to predict the probability of Axonics Modulation's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axonics Modulation's price. Additionally, you may evaluate how the addition of Axonics Modulation to your portfolios can decrease your overall portfolio volatility.